Bragar Eagel & Squire, P.C. Urges Agilon, Soleno, Avita, and Coty Investors to Reach Out About Current Investigations
Agilon Health Investigation: Bragar Eagel & Squire, P.C. is investigating Agilon Health for potential violations of federal securities laws following the unexpected resignation of its CEO and the withdrawal of its earnings guidance, which led to a significant drop in share price.
Soleno Therapeutics Report: The law firm is also looking into Soleno Therapeutics after a report from Scorpion Capital criticized its product, Vykat XR, as overpriced and unsafe, resulting in a notable decline in the company's stock price.
AVITA Medical Claims Backlog: AVITA Medical is under investigation due to a reported backlog of unpaid claims for its Recell procedures, which negatively impacted its financial results and led to a sharp decrease in share price.
Coty's Financial Losses: Coty, Inc. is facing scrutiny after reporting an unexpected financial loss and disappointing guidance, attributed to broader market challenges, which caused its stock price to fall significantly.
Trade with 70% Backtested Accuracy
Analyst Views on AGL
About AGL
About the author

- Shareholder Rights Protection: Halper Sadeh LLC is investigating whether certain executives of Agilon Health, Inc. breached their fiduciary duties to shareholders, potentially leading to financial losses for investors and highlighting the importance of corporate governance.
- Legal Fee Arrangement: The firm promises to handle related matters on a contingent fee basis, ensuring that shareholders do not incur additional financial burdens when seeking legal remedies, thereby lowering the barrier for shareholder participation.
- Importance of Shareholder Involvement: Shareholder participation can drive improvements in company policies and oversight mechanisms, enhancing transparency and accountability, which ultimately helps to increase shareholder value and demonstrates the power of collective action.
- Global Investor Representation: Halper Sadeh LLC represents investors worldwide, focusing on combating securities fraud and corporate misconduct, having successfully implemented corporate reforms and recovered millions for defrauded investors, showcasing its expertise in protecting investor rights.
- Market Performance: Gas utilities stocks collectively rose by approximately 1.2%, indicating relative strength in the market and reflecting a gradual recovery in investor confidence towards the sector.
- Leading Companies: Stabilis Solutions saw its stock price increase by about 6.4%, making it the top performer of the day, suggesting its growing competitiveness and investment appeal in the market.
- Other Company Dynamics: Chesapeake Utilities' stock rose by approximately 1.8%, further solidifying its market position in the gas utilities sector, which may attract more investor attention.
- Industry Trends: With hospital and medical practitioners also showing strong performance, the rise in gas utilities could signal a broader economic recovery, prompting investors to monitor the implications of this trend on future market conditions.
- Advertising Sector Uptrend: Advertising stocks collectively rose by approximately 2.5% on Monday, indicating a renewed market confidence in the sector, which may reflect expectations of increased advertising spending and subsequently boost related companies' performance.
- Advantage Solutions Leads: Advantage Solutions saw its stock price surge by about 9.7%, positioning it as the leader among advertising stocks, suggesting investor optimism regarding its future growth potential, possibly linked to recent business expansions or new client acquisition strategies.
- National CineMedia Strong Performance: National CineMedia's stock increased by approximately 6.5%, reflecting market confidence in its cinema advertising segment, likely benefiting from the recovery of the film industry and the return of audiences to theaters, which could enhance advertising revenues.
- Positive Industry Outlook: The robust performance of advertising stocks may signal overall economic recovery, with investors maintaining an optimistic view on increased advertising expenditures, which will likely enhance the profitability and market valuations of related companies.

- Reverse Stock Split: Agilon Health announced a 1-for-25 reverse stock split effective March 30, 2026, to comply with NYSE minimum bid price requirements, with trading on a split-adjusted basis starting March 31, aiming to lift its share price for continued listing compliance.
- Shareholder Approval: At a special meeting on March 17, shareholders approved the reverse split proposal ranging from 1-for-5 to 1-for-25, with the board opting for the 1-for-25 ratio, reflecting the company's responsiveness to shareholder input.
- Reduction in Outstanding Shares: Following the reverse split, Agilon Health's outstanding shares will decrease from approximately 415 million to about 16.6 million, which is expected to enhance the stock's marketability and liquidity, potentially attracting more investor interest.
- Value-Based Care Model: Agilon Health partners with physician groups and health systems to support a value-based care model for senior patients, providing technology, capital, and operational support, although the market remains cautious about its investment potential, it is still viewed as a stock with upside potential.
- Inflation Impact: On Wednesday, major U.S. indices closed lower after two days of gains, with the S&P 500 down 1.4%, the Nasdaq Composite down 1.5%, and the Dow Jones Industrial Average down 1.6%, reflecting investor concerns over hotter-than-expected wholesale inflation data.
- Micron Technology Earnings: Despite Micron Technology (MU) reporting adjusted earnings of $12.20 per share and revenue of $23.86 billion, both significantly exceeding Wall Street expectations with a 196.4% year-over-year increase, its shares fell approximately 3.5% in after-hours trading, indicating market caution regarding future performance.
- Five Below Sales Surge: Five Below (FIVE) saw its shares rise in after-hours trading following a 24.5% year-over-year sales increase to $1.73 billion in fiscal Q4, well above the 13.7% consensus estimate, with comparable sales jumping 15.3%, showcasing strong consumer demand and market performance.
- agilon health Stock Split: Agilon health (AGL) announced a 1-for-25 reverse stock split effective March 30, 2026, aimed at raising its share price above $1.00 to meet NYSE listing requirements, thereby improving stock liquidity and marketability to attract broader investor interest.
- Reverse Stock Split Plan: Agilon Health (AGL) has announced a 1-for-25 reverse stock split effective March 30, 2026, aimed at raising its share price above $1.00 to meet NYSE listing requirements.
- Trading Adjustment Date: Post-split, shares will begin trading on a split-adjusted basis starting March 31, 2026, which is expected to enhance stock liquidity and market appeal.
- Increased Investor Interest: By elevating its stock price, Agilon Health aims to attract broader investor interest, thereby enhancing its market competitiveness and investment attractiveness.
- Financial Outlook: Agilon Health projects $5.5 billion in revenue for 2026, with a breakeven adjusted EBITDA amid transformation and disciplined contracting, indicating the company's potential in the value-based care sector.










